TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference

AI Briefing

• – TuHURA Biosciences to present at the 4th Annual H.C. Wainwright BioConnect Investor Conference.
• – Company developing novel therapeutics to overcome resistance to cancer immunotherapy.
• – TuHURA Biosciences to be discussed by James A. Bianco, M.D., President and Chief